相关实验视频

Updated: Jan 11, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

第2次GenE-HumDi (COST行动2113) 年度会议记录

María Ortiz-Bueno¹, Iris Ramos-Hernández¹, Luis Algeciras-Jiménez¹

¹GENYO, Centre for Genomics and Oncological Research: Pfizer, University of Granada, Andalusian Regional Government PTS Granada, Granada, Spain.

Frontiers in genome editing

|November 19, 2025

概括

通过促进合作和确定优先事项,GenE-HumDi网络加速了人类疾病的基因组编辑 (GE) 疗法. 这次会议总结了转基因医学的关键发展和挑战,指导了未来的欧洲研究和应用.

科学领域:

生物技术和生物医学科学生物技术和生物医学科学
遗传学和基因组学遗传学和基因组学
监管科学监管科学

背景情况:

该GenE-HumDi COST行动旨在团结学术,工业和医疗保健部门,以简化基因组编辑 (GE) 治疗的批准.
它通过赠款,教育和网络支持研究人员,以推进基因组医学的开发和应用.
该倡议的重点是促进国际合作,特别是在GE领域的早期职业科学家.

研究的目的:

编制和传播第二届年度GenE-HumDi会议的会议记录和主要成果.
确定欧洲转基因疗法的研究,开发和临床应用的当前挑战和未来优先事项.
促进GE医学领域的利益相关者之间的协同互动和合作.

主要方法:

在2024年在塞浦路斯利马索尔召开第二届GenE-HumDi年会.
组织七个专注的讨论小组,涵盖GE工具,交付,安全,验证,制造和监管.
收集知名专家关于转基因疗法的最新发现和正在进行的项目的最新信息.

主要成果:

超过70名成员和科学家讨论了转基因医学的现状和未来方向.
识别了GE工具开发,交付,安全,验证,制造和监管途径的知识,标准化和传播方面的关键差距.
强调需要协调行动和加强合作,以推进欧洲的转基因疗法.

结论:

会议的成果是欧洲转基因疗法的发展和应用的战略指南.
强调解决发现的差距的重要性,以加快转基因药物的开发和批准.
加强了GenE-HumDi在协调努力和促进人类疾病的GE领域的关键发展方面的作用.

关键词:

这是ATMP规则.基因治疗的基因疗法基因组编辑基因组编辑统一化和化统一化和化分子医学是分子医学.科学网络科学网络标准标准标准标准标准翻译医学是一种翻译医学.

更多相关视频

Hi-C: A Method to Study the Three-dimensional Architecture of Genomes.

Hi-C: A Method to Study the Three-dimensional Architecture of Genomes.

Published on: May 6, 2010

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Amplification of Near Full-length HIV-1 Proviruses for Next-Generation Sequencing

Published on: October 16, 2018

相关概念视频

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

Gene Families

Gene Families

Gene Families

Gene Families

Gene families consist of groups of genes proposed to have originated from a common ancestor. Typically these arise through events in which a gene or genes are mistakenly duplicated during cell division. Unlike their parent genes (which are subject to selection pressure to maintain function), these gene copies do not need to preserve their sequences and may evolve at a relatively faster rate.
Occasionally these regions can be adapted to take on new roles within the organism, becoming novel genes...

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...